相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。GDF15 Induces Anorexia through Nausea and Emesis
Tito Borner et al.
CELL METABOLISM (2020)
Cisplatin-Induced Skeletal Muscle Dysfunction: Mechanisms and Counteracting Therapeutic Strategies
Elena Conte et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
GDF15 Induces an Aversive Visceral Malaise State that Drives Anorexia and Weight Loss
Tito Borner et al.
CELL REPORTS (2020)
The cytokine GDF15 signals through a population of brainstem cholecystokinin neurons to mediate anorectic signalling
Amy A. Worth et al.
ELIFE (2020)
Antibody-mediated inhibition of GDF15-GFRAL activity reverses cancer cachexia in mice
Rowena Suriben et al.
NATURE MEDICINE (2020)
Characterization of cachexia in the human fibrosarcoma HT-1080 mouse tumour model
Barbara Bernardo et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2020)
One shot NEPA plus dexamethasone to prevent multiple-day chemotherapy in sarcoma patients
Giuseppe Badalamenti et al.
SUPPORTIVE CARE IN CANCER (2019)
Chemotherapy-induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol
Daniel I. Brierley et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)
GDF15 mediates adiposity resistance through actions on GFRAL neurons in the hindbrain AP/NTS
Vicky Wang-Wei Tsai et al.
INTERNATIONAL JOURNAL OF OBESITY (2019)
Effects of ondansetron and [6]-gingerol on pica and gut microbiota in rats treated with cisplatin
Xiaodi Feng et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
GDF15 Provides an Endocrine Signal of Nutritional Stress in Mice and Humans
Satish Patel et al.
CELL METABOLISM (2019)
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)
Brian Rini et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Oxaliplatin induces muscle loss and muscle-specific molecular changes in Mice
Claire E. Feather et al.
MUSCLE & NERVE (2018)
Preventing chemotherapy-induced nausea and vomiting in patients with lung cancer: efficacy of NEPA (netupitant-palonosetron), the first combination antiemetic
Paul J. Hesketh et al.
SUPPORTIVE CARE IN CANCER (2018)
GDF15 promotes the proliferation of cervical cancer cells by phosphorylating AKT1 and Erk1/2 through the receptor ErbB2
Shan Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Fenofibrate prevents skeletal muscle loss in mice with lung cancer
Marcus D. Goncalves et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
The Parabrachial Nucleus: CGRP Neurons Function as a General Alarm
Richard D. Palmiter
TRENDS IN NEUROSCIENCES (2018)
Growth differentiation factor 15 in a community-based sample: age-dependent reference limits and prognostic impact
Steven Doerstling et al.
UPSALA JOURNAL OF MEDICAL SCIENCES (2018)
Vomiting in pregnancy is associated with a higher risk of low birth weight: a cohort study
Clive J. Petry et al.
BMC PREGNANCY AND CHILDBIRTH (2018)
Cancer-associated cachexia
Vickie E. Baracos et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Evidence GDF15 Plays a Role in Familial and Recurrent Hyperemesis Gravidarum
Marlena S. Fejzo et al.
GEBURTSHILFE UND FRAUENHEILKUNDE (2018)
Oncologist perspectives on chemotherapy-induced nausea and vomiting (CINV) management and outcomes: A quantitative market research-based survey
Matti Aapro et al.
CANCER REPORTS (2018)
Found in Translation: Maximizing the Clinical Relevance of Nonclinical Oncology Studies
Mary E. Spilker et al.
CLINICAL CANCER RESEARCH (2017)
2016 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting
Lawrence H. Einhorn et al.
SUPPORTIVE CARE IN CANCER (2017)
Butyrylcholinesterase regulates central ghrelin signaling and has an impact on food intake and glucose homeostasis
V. P. Chen et al.
INTERNATIONAL JOURNAL OF OBESITY (2017)
NF-κB regulates GDF-15 to suppress macrophage surveillance during early tumor development
Nivedita M. Ratnam et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
Paul J. Hesketh et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Growth Differentiation Factor-15 and Risk of CKD Progression
Viji Nair et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
NCCN Guidelines® Insights Antiemesis, Version 2.2017 Featured Updates to the NCCN Guidelines
Michael J. Berger et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Non - homeostatic body weight regulation through a brainstem-restricted receptor for GDF15
Jer-Yuan Hsu et al.
NATURE (2017)
GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand
Linda Yang et al.
NATURE MEDICINE (2017)
GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates
Shannon E. Mullican et al.
NATURE MEDICINE (2017)
The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL
Paul J. Emmerson et al.
NATURE MEDICINE (2017)
Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations
Matti Aapro et al.
SUPPORTIVE CARE IN CANCER (2017)
A novel preventive therapy for paclitaxel-induced cognitive deficits: preclinical evidence from C57BL/6 mice
P. Huehnchen et al.
TRANSLATIONAL PSYCHIATRY (2017)
BGP-15 Protects against Oxaliplatin-Induced Skeletal Myopathy and Mitochondrial Reactive Oxygen Species Production in Mice
James C. Sorensen et al.
FRONTIERS IN PHARMACOLOGY (2017)
Overall Survival Following Neoadjuvant Chemotherapy vs Primary Cytoreductive Surgery in Women With Epithelial Ovarian Cancer Analysis of the National Cancer Database
J. Alejandro Rauh-Hain et al.
JAMA ONCOLOGY (2017)
ACVR2B/Fc counteracts chemotherapy-induced loss of muscle and bone mass
Rafael Barreto et al.
SCIENTIFIC REPORTS (2017)
A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice
Wayne J. Aston et al.
BMC CANCER (2017)
GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease
Carlos H. Martinez et al.
RESPIRATORY RESEARCH (2017)
Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction
Michelle M. Y. Chan et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
GDF15 promotes EMT and metastasis in colorectal cancer
Chen Li et al.
ONCOTARGET (2016)
MAP3K11/GDF15 axis is a critical driver of cancer cachexia
Lorena Lerner et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2016)
Excitatory Hindbrain–Forebrain Communication Is Required for Cisplatin-Induced Anorexia and Weight Loss
Amber L. Alhadeff et al.
JOURNAL OF NEUROSCIENCE (2016)
ActRII blockade protects mice from cancer cachexia and prolongs survival in the presence of anti-cancer treatments
Shinji Hatakeyama et al.
SKELETAL MUSCLE (2016)
Risk Model-Guided Antiemetic Prophylaxis vs Physician's Choice in Patients Receiving Chemotherapy for Early-Stage Breast Cancer A Randomized Clinical Trial
Mark Clemons et al.
JAMA ONCOLOGY (2016)
GDF 15 - A Novel Biomarker in the Offing for Heart Failure
Melvin George et al.
CURRENT CARDIOLOGY REVIEWS (2016)
Weight control interventions improve therapeutic efficacy of dacarbazine in melanoma by reversing obesity-induced drug resistance
Parmanand Malvi et al.
CANCER & METABOLISM (2016)
Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab
Mary Putt et al.
CLINICAL CHEMISTRY (2015)
Alkylating Agent Melphalan Augments the Efficacy of Adoptive Immunotherapy Using Tumor-Specific CD4+ T Cells
Xiaoyun Lu et al.
JOURNAL OF IMMUNOLOGY (2015)
Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15) Gene Deletion Promotes Cancer Growth in TRAMP Prostate Cancer Prone Mice
Yasmin Husaini et al.
PLOS ONE (2015)
Growth Differentiation Factor 15 (GDF-15) Plasma Levels Increase during Bleomycin- and Cisplatin-Based Treatment of Testicular Cancer Patients and Relate to Endothelial Damage
Renske Altena et al.
PLOS ONE (2015)
Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients
Lorena Lerner et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2015)
Ghrelin prevents tumour- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved
Ji-an Chen et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2015)
Association of Serum Level of Growth Differentiation Factor 15 with Liver Cirrhosis and Hepatocellular Carcinoma
Xiuying Liu et al.
PLOS ONE (2015)
Knockdown of platinum-induced growth differentiation factor 15 abrogates p27-mediated tumor growth delay in the chemoresistant ovarian cancer model A2780cis
Julia C. Meier et al.
CANCER MEDICINE (2015)
Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin, Taxanes, and Trastuzumab
Bonnie Ky et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Quantitative determination of platinum derived from cisplatin in human plasma ultrafiltrate using derivatization with diethyldithiocarbamate and liquid chromatography coupled with electrospray ionization tandem mass spectrometry
Caiming Tang et al.
ANALYTICAL METHODS (2013)
Platinum compounds in children with cancer: toxicity and clinical management
Antonio Ruggiero et al.
ANTI-CANCER DRUGS (2013)
Growth-differentiation factor-15 and tissue doppler imaging in detection of asymptomatic anthracycline cardiomyopathy in childhood cancer survivors
Derya Arslan et al.
CLINICAL BIOCHEMISTRY (2013)
TNF-alpha and melphalan modulate a specific group of early expressed genes in a murine melanoma model
Vladmir Claudio Cordeiro de Lima et al.
CYTOKINE (2013)
Inhibition of Cisplatin-Induced Lipid Catabolism and Weight Loss by Ghrelin in Male Mice
Jose M. Garcia et al.
ENDOCRINOLOGY (2013)
Determination of cisplatin in blood plasma by liquid chromatography with mass spectrometry detection
D. V. Yaroshenko et al.
JOURNAL OF ANALYTICAL CHEMISTRY (2013)
TGF-b Superfamily Cytokine MIC-1/GDF15 Is a Physiological Appetite and Body Weight Regulator
Vicky Wang-Wei Tsai et al.
PLOS ONE (2013)
Development of doxorubicin-induced chronic cardiotoxicity in the B6C3F1 mouse model
Varsha G. Desai et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Prospective validation of risk prediction indexes for acute and delayed chemotherapy-induced nausea and vomiting
N. Bouganim et al.
CURRENT ONCOLOGY (2012)
GDF-15: a novel serum marker for metastases in uveal melanoma patients
Daniela Suesskind et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2012)
Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15) Slows Cancer Development but Increases Metastases in TRAMP Prostate Cancer Prone Mice
Yasmin Husaini et al.
PLOS ONE (2012)
Definition and classification of cancer cachexia: an international consensus
Kenneth Fearon et al.
LANCET ONCOLOGY (2011)
Effects of multiple doses of cyclophosphamide on mouse testes: Accessing the germ cells lost, and the functional damage of stem cells
Ana Luiza Drumond et al.
REPRODUCTIVE TOXICOLOGY (2011)
Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity-state of the art
Steven M. Grunberg et al.
SUPPORTIVE CARE IN CANCER (2011)
GDF-15 Contributes to Proliferation and Immune Escape of Malignant Gliomas
Patrick Roth et al.
CLINICAL CANCER RESEARCH (2010)
Distinct mechanistic activity profile of pralatrexate in comparison to other antifolates in in vitro and in vivo models of human cancers
E. Izbicka et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Effective Treatment of Advanced Human Melanoma Metastasis in Immunodeficient Mice Using Combination Metronomic Chemotherapy Regimens
William Cruz-Munoz et al.
CLINICAL CANCER RESEARCH (2009)
Expression of Macrophage Inhibitory Cytokine-1 in Prostate Cancer Bone Metastases Induces Osteoclast Activation and Weight Loss
Savita Wakchoure et al.
PROSTATE (2009)
Skeletal Muscle Diseases, Inflammation, and NF-kappa B Signaling: Insights and Opportunities for Therapeutic Intervention
Jennifer M. Peterson et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2008)
Oxaliplatin doublets in non-small cell lung cancer: A literature review
Diego Cortinovis et al.
LUNG CANCER (2008)
Squalene selectively protects mouse bone marrow progenitors against cisplatin and carboplatin-induced cytotoxicity in vivo without protecting tumor growth
Bikul Das et al.
NEOPLASIA (2008)
Tumor-induced anorexia and weight loss are mediated by the TGF-β superfamily cytokine MIC-1
Heiko Johnen et al.
NATURE MEDICINE (2007)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Cisplatin-versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: An individual patient data meta-analysis
Andrea Ardizzoni et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Weekly administration of paclitaxel induces long-term aneugenicity in nude mice
Carlos M. Galmarini et al.
CANCER BIOLOGY & THERAPY (2007)
Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia
Seung Joon Baek et al.
GASTROENTEROLOGY (2006)
Pharmacokinetic-pharmacodynamic modeling of methotrexate-induced toxicity in mice
ED Lobo et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1
M Albertoni et al.
ONCOGENE (2002)
分享论文
